Skip to main content
All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

Lobbying for GILEAD SCIENCES, INC. · A Life-Science Company advancing therapies against life-threatening diseases

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $80,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 3
Budget/Appropriations

federal budget issues

Health Issues

IRA, pharmaceuticals access and affordability, drug pricing in federal programs, HCV screening, drug pricing and access, HIV, oncology, PAHPA reauthorization

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem